Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0641-6044-25 · Lorazepam Injection · Hikma Pharmaceuticals USA, Inc.
What is the package ndc for 0641-6044-25 · Lorazepam Injection · Hikma Pharmaceuticals USA, Inc.?
For 0641-6044-25 · Lorazepam Injection · Hikma Pharmaceuticals USA, Inc., package ndc is 0641-6044-25; generic name is Lorazepam Injection; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-01.
"initial_posting_date": "09/05/2018", "package_ndc": "0641-6044-25", "generic_name": "Lorazepam Injection", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Lots are being manufactured to meet demand"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0641-6044-25 verified
- Generic name
- Lorazepam Injection verified
- Manufacturer
- Hikma Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Limited Availability verified
- FDA note
- Lots are being manufactured to meet demand verified
- Initial posting date
- 09/05/2018 verified
- Last update date
- 08/13/2026 verified
- Days in shortage
- 2918 our reading
- Reason for shortage
- Demand increase for the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Neurology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/13/2026", "therapeutic_category": [ "Neurology" ], "dosage_form": "Injection", "presentation": "Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
The same source also states
"initial_posting_date": "09/05/2018", "package_ndc": "0641-6044-25", "generic_name": "Lorazepam Injection", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Estimated recovery: TBD"
— api.fda.gov, retrieved 2026-09-10
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000